Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

MHRA outlines strategic approach to AI regulation in healthcare for patient safety

MHRA outlines strategic approach to AI regulation in healthcare for patient safety
MHRA's strategic principles aim to foster innovation while upholding rigorous standards of patient safety and regulatory integrity

In a recent announcement the Medicines and Healthcare products Regulatory Agency (MHRA) unveiled its strategic approach to artificial intelligence (AI), as it sets out to embrace the transformative potential of AI in healthcare regulation.

Building upon the Government's white paper 'A pro-innovation approach to AI regulation', released in 2023, the MHRA outlined five key strategic principles guiding its adoption of AI.


These principles encompass safety, security, and robustness; appropriate transparency and explainability; fairness, accountability, and governance; and contestability and redress.

A science-led organization, the MHRA was tasked with providing an independent view of its approach to AI in medicine and science, aligning with a government white paper.

Recognising its role in UK's goal to be a science and tech leader by 2030, MHRA is tasked to evaluate AI's opportunities and risks across regulatory, public service, and evidence-based decision-making area.

Dr. Laura Squire, Chief Quality and Access Officer at the MHRA, emphasised the agency's commitment to leveraging AI to enhance regulatory efficiency while ensuring proportional risk management.

Squire said, "AI offers us the opportunity to improve the efficiency of the services we provide across all our regulatory functions, through enabling safe access for medicines and medical devices, to post market surveillance and enforcement."

"While taking this opportunity we must ensure there is risk proportionate regulation of AI as a Medical Device (AIaMD) which takes into account the risks of these products without stifling the potential they have to transform healthcare."

Health and Social Care Secretary, Victoria Atkins, echoed Dr. Squire's sentiments, highlighting the potential of AI to revolutionise healthcare delivery as AI "is already transforming the way we deliver healthcare, cutting waiting lists for patients and freeing up time for NHS staff."

Atkins emphasised the importance of harnessing technology to create a faster, simpler, and fairer healthcare system as  in recent announcement the government has allocated "a £3.4 billion investment in the latest technology for the NHS, to help doctors and nurses focus on patients rather than admin."

She praised the MHRA's principles as essential in ensuring the safe and transparent integration of AI across the health service.

The MHRA's approach reflects a dual focus on innovation and patient safety, aiming to fast-track access to medical products while maintaining rigorous regulatory standards.

The agency's ongoing regulatory reform program includes risk proportionate regulation of AI as a medical device (AIaMD), recognising the need for flexible regulation to accommodate evolving technology "as in the coming years AI is likely to be integral to ensuring effective product regulation and patient safety."

More For You

Community Pharmacy England (CPE) chief executive Janet Morrison was one of the signatories of the statement

Community Pharmacy England (CPE) chief executive Janet Morrison was one of the signatories of the statement

Primary care leaders join forces in effort to 'transform investment into primary care'

Community Pharmacy England (CPE) has teamed up with other national primary care bodies to urge the government to allocate more funds towards the sector.

In a joint statement released on the back of the government’s spending review, last week, the organisations welcomed the government’s continued determination to ‘shift care from hospitals to community and from sickness to prevention’ but warned that this would not be possible ‘without further investment in primary care’.

Keep ReadingShow less
Cancer patients warned against using weight-loss jabs

Macmillan Cancer Support said there is not enough evidence on how the weight-loss jabs might affect anti-cancer treatments.

iStock

Cancer patients warned against using weight-loss jabs

Cancer patients have been advised to consult their doctor before taking any weight-loss jabs.

Macmillan Cancer Support has issued this advisory following a surge in calls by cancer patients asking whether they can take fat loss jabs such as Wegovy and Mounjaro.

Keep ReadingShow less
Kamson Pharmacy to deliver more clinical services after installing hub and spoke technology

The FLOWRx auto hub in the new Kamson warehouse in Uckfield.

Kamson Pharmacy to deliver more clinical services after installing hub and spoke technology


Kamsons Pharmacy has announced that it has implemented a state-of-the-art hub and spoke dispensing model with the aim of freeing up more time to deliver clinical services.

Keep ReadingShow less
RPS group aims to tackle barriers holding back black pharmacy students

Work is underway to improve inclusivity in teaching

Pic credit: iStock

RPS group aims to tackle barriers holding back black pharmacy students

A cross-sector group aimed at tackling barriers that block the progression of black students and trainee pharmacists held its first meeting this week.

The Royal Pharmaceutical Society (RPS) has created the Differential Attainment Oversight Group to address issues that black or black British African student pharmacists and foundation trainees face such as limited access to work experience, financial support and visible role models in education and training.

Keep ReadingShow less
Older adult organizing medicine bottles in a cool, dry storage area during warm weather.

People are being advised to keep medicine below 25° C

Pic credit: iStock

Pharmacies advise patients on storing medicines safely during heatwave

Patients are being given important advice and guidance on the impact heat can have on their medicine and where to keep different medicines as the UK goes through a heatwave.

People are being advised to keep medicine below 25° C if they are able to, unless storage instructions state it needs to be kept at an alternative temperature, such as drugs that need to be refrigerated.

Keep ReadingShow less